Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
出版年份 2019 全文链接
标题
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
作者
关键词
-
出版物
mAbs
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2019-04-16
DOI
10.1080/19420862.2019.1608143
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibodies to watch in 2018
- (2018) Hélène Kaplon et al. mAbs
- Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation
- (2018) Chiu-Ping Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
- (2018) Masato Kiyoshi et al. Scientific Reports
- Effects of amino acid substitutions on the biological activity of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
- (2018) Michihiko Aoyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A single amino acid distorts the Fc γ receptor IIIb/CD16b structure upon binding immunoglobulin G1 and reduces affinity relative to CD16a
- (2018) Jacob T. Roberts et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms
- (2018) Ryuta Wada et al. mAbs
- Structure and activation of C1, the complex initiating the classical pathway of the complement cascade
- (2017) Simon A. Mortensen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IgG Fc engineering to modulate antibody effector functions
- (2017) Xinhua Wang et al. Protein & Cell
- Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity
- (2017) Benjamin Peschke et al. Frontiers in Immunology
- Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
- (2017) Wei Li et al. Frontiers in Immunology
- Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins
- (2016) John P. Giddens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies
- (2016) Marco Thomann et al. MOLECULAR IMMUNOLOGY
- Fc glycans of therapeutic antibodies as critical quality attributes
- (2015) Dietmar Reusch et al. GLYCOBIOLOGY
- Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods
- (2015) Dietmar Reusch et al. mAbs
- Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
- (2015) Minoru Tada et al. mAbs
- The Structural Role of Antibody N-Glycosylation in Receptor Interactions
- (2015) Ganesh P. Subedi et al. STRUCTURE
- Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
- (2015) Masami Suzuki et al. Journal of Toxicologic Pathology
- In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity
- (2015) Marco Thomann et al. PLoS One
- Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities
- (2015) Masaki Kurogochi et al. PLoS One
- Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
- (2015) Tetyana Dashivets et al. PLoS One
- Development of a Cell-Based Assay Measuring the Activation of FcγRIIa for the Characterization of Therapeutic Monoclonal Antibodies
- (2014) Minoru Tada et al. PLoS One
- Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab
- (2013) Jan Visser et al. BIODRUGS
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions
- (2012) Wei Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Galactosylation variations in marketed therapeutic antibodies
- (2012) T. Shantha Raju et al. mAbs
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection
- (2012) ANNA FRITZ-RDZANEK et al. Oncology Letters
- Separation of post-translational modifications in monoclonal antibodies by exploiting subtle conformational changes under mildly acidic conditions
- (2010) Shiyi Wang et al. JOURNAL OF CHROMATOGRAPHY A
- Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
- (2010) Damian Houde et al. MOLECULAR & CELLULAR PROTEOMICS
- Efficient Synthesis of Sugar Oxazolines from UnprotectedN-Acetyl-2-amino Sugars by Using Chloroformamidinium Reagent in Water
- (2009) Masato Noguchi et al. JOURNAL OF ORGANIC CHEMISTRY
- Terminal sugars of Fc glycans influence antibody effector functions of IgGs
- (2008) T Shantha Raju CURRENT OPINION IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More